Eui-Jong Kwon

Dr. Eui-Jong Kwon

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
SJSunhee Jang
Sunhee Jang
EKEui-Jong Kwon
Eui-Jong Kwon
JLJennifer Jooha Lee
Jennifer Jooha Lee
Rheumatoid arthritis (RA) is a chronic, systemic autoimmune disease associated with synovial tissue proliferation, pannus formation, cartilage destruction, and systemic complications. Currently, advanced understandings of the pathologic mechanisms of autoreactive CD4+ T cells, B cells, macrophages, inflammatory cytokines, chemokines, and autoantibodies that cause RA have been achieved, despite the fact that much remains to be elucidated. This review provides an updated pathogenesis of RA which will unveil novel therapeutic targets.

Verified
Journal Article
Open access
PDF file
EKEui-Jong Kwon
Eui-Jong Kwon
JJJi Hyeon Ju
Ji Hyeon Ju
Rheumatoid arthritis (RA) is caused by prolonged periodic interactions between genetic, environmental, and immunologic factors. Posttranslational modifications (PTMs) such as citrullination, carbamylation, and acetylation are correlated with the pathogenesis of RA. PTM and cell death mechanisms such as apoptosis, autophagy, NETosis, leukotoxic hypercitrullination (LTH), and necrosis are related to each other and induce autoantigenicity. Certain microbial infections, such as those caused by Porphyromonasgingivalis, Aggregatibacter actinomycetemcomitans, and Prevotella copri, can induce autoantigens in RA. Anti-modified protein antibodies (AMPA) containing anti-citrullinated protein/peptide antibodies (ACPAs), anti-carbamylated protein (anti-CarP) antibodies, and anti-acetylated protein antibodies (AAPAs) play a role in pathogenesis as well as in prediction, diagnosis, and prognosis. Interestingly, smoking is correlated with both PTMs and AMPAs in the development of RA. However, there is lack of evidence that smoking induces the generation of AMPAs.

20 January 2025 in Journal of Rheumatic Diseases
Verified
Journal Article
Open access
PDF file
BLBong-Woo Lee
Bong-Woo Lee
EKEui-Jong Kwon
Eui-Jong Kwon
JJJi Hyeon Ju
Ji Hyeon Ju
Bong-Woo Lee, M.D., Eui-Jong Kwon, M.D., Ji Hyeon Ju, M.D., Ph.D.. J Rheum Dis 2025;32:154-65. https://doi.org/10.4078/jrd.2024.0122

12 June 2024 in Journal of Rheumatic Diseases
Verified
Journal Article
Open access
PDF file
EKEui-Jong Kwon
Eui-Jong Kwon
YPYoungjae Park
Youngjae Park
SKSeung-Ki Kwok
Seung-Ki Kwok
JJJi Hyeon Ju
Ji Hyeon Ju
Eui-Jong Kwon, M.D., Youngjae Park, M.D., Ph.D., Seung-Ki Kwok, M.D., Ph.D., Ji Hyeon Ju, M.D., Ph.D.. J Rheum Dis -0001;0:. https://doi.org/10.4078/jrd.2024.0043

Verified
Journal Article
Open access
PDF file
EKEui-Jong Kwon
Eui-Jong Kwon
BLBong-Woo Lee
Bong-Woo Lee
JJJi Hyeon Ju
Ji Hyeon Ju
Sjögren’s disease (SjD) is a chronic autoimmune disease characterized by lymphocytic infiltration and dysfunction of the exocrine glands, with manifestations extending beyond glandular sicca symptoms to multiple extraglandular systems. Although the pathogenesis of SjD remains incompletely understood, growing evidence indicates that a complex cytokine network involving both innate and adaptive immune pathways plays a central role in disease development. This narrative review summarizes recent updates on cytokine signaling in SjD across three clinically relevant domains. In glandular inflammation, activation of salivary gland epithelial cells through Toll-like receptor pathways triggers type I interferon (IFN) signaling via plasmacytoid dendritic cells, while IFN-γ, Th17-related cytokines (IL-6, IL-17, IL-22), BAFF/APRIL, and chemokines (CXCL10, CXCL12, CXCL13) collectively sustain local inflammation and ectopic lymphoid organization. The BAFF/APRIL axis, a systemic type I IFN signature, and IL-21–follicular helper T cell–B cell interactions primarily drive systemic immune activation, which together underlie autoantibody production, hypergammaglobulinemia, and a lymphoma-prone phenotype. In contrast, constitutional symptoms such as fatigue, pain, and dryness frequently dissociate from classical inflammatory activity and are better explained by neuroimmune–metabolic mechanisms, including the IFN-γ–IDO–kynurenine pathway and symptom-associated proteomic signatures. Collectively, these findings underscore the heterogeneous nature of SjD, in which glandular inflammation, systemic immune activation, and constitutional symptoms are driven by distinct yet partially overlapping cytokine pathways. Recognizing this heterogeneity has direct implications for cytokine-targeted therapy, suggesting that future trials should stratify patients by disease phenotype (IFN-high, B cell-dominant, and symptom-dominant) rather than treating SjD as a uniform population.

1 January 2023 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
JYJiwon Yang
Jiwon Yang
YRYoungwook Ryu
Youngwook Ryu
HJHowook Jeon
Howook Jeon
EKEui-Jong Kwon
Eui-Jong Kwon
KPKyung-Su Park
Kyung-Su Park
YPYoungjae Park
Youngjae Park
Yang J, et al. J Korean Med Sci. 2023 Oct;38(40):e327. https://doi.org/10.3346/jkms.2023.38.e327